G A Spinas Selected Research

Therapeutics

8/2009	Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland.
8/2002	[General insulin therapy practice in type 2 diabetes mellitus].
1/2000	The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G A Spinas Research Topics

Disease

12	Type 2 Diabetes Mellitus (MODY) 07/2013 - 01/2000
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2013 - 08/2001
3	Diabetes Complications 02/2013 - 07/2005
3	Insulin Resistance 01/2010 - 05/2002
3	Insulinoma 10/2004 - 09/2001
2	Myocardial Infarction 08/2009 - 01/2000
2	Overweight 10/2008 - 07/2000
2	Hypoglycemia (Reactive Hypoglycemia) 06/2008 - 10/2004
2	Ulcer 01/2008 - 08/2002
2	Osteomyelitis 01/2008 - 08/2002
2	Magnesium Deficiency (Deficiency, Magnesium) 02/2006 - 05/2002
2	Diabetes Mellitus 07/2005 - 08/2001
2	Hypertension (High Blood Pressure) 08/2002 - 05/2002
1	Atherosclerosis 01/2010
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2008
1	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2008
1	Inflammation (Inflammations) 10/2008
1	Diabetic Foot 01/2008
1	Foot Ulcer 01/2008
1	Renal Insufficiency (Renal Failure) 07/2005
1	Neoplasms (Cancer) 10/2004
1	Gastroparesis 08/2003
1	Peripheral Arterial Disease 08/2002
1	Infections 08/2002
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2002
1	Dyslipidemias (Dyslipidemia) 08/2002
1	Thrombosis (Thrombus) 05/2002
1	Body Weight (Weight, Body) 09/2001
1	Noninsulin-dependent diabetes mellitus with deafness 07/2001
1	Eye Diseases (Eye Disease) 01/2000
1	Ketosis 01/2000
1	Stroke (Strokes) 01/2000
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2000

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 07/2013 - 01/2000
10	Insulin (Novolin)FDA Link 07/2013 - 01/2000
5	LipidsIBA 01/2010 - 01/2000
3	HDL CholesterolIBA 01/2009 - 01/2001
2	oxidized low density lipoproteinIBA 01/2010 - 12/2008
2	C-Reactive ProteinIBA 01/2010 - 01/2008
2	Lipoproteins (Lipoprotein)IBA 01/2009 - 12/2008
2	HDL LipoproteinsIBA 01/2009 - 01/2001
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2008 - 08/2002
2	CalciumIBA 10/2004 - 09/2001
2	SecretagoguesIBA 10/2004 - 09/2001
2	Glucagon (Glukagon)FDA Link 10/2004 - 07/2001
1	SmokeIBA 02/2013
1	Interleukin-18 (Interleukin 18)IBA 01/2010
1	Insulin Glargine (Lantus)FDA Link 08/2009
1	Exenatide (Byetta)FDA Link 08/2009
1	ApolipoproteinsIBA 01/2009
1	LDL CholesterolIBA 01/2009
1	Triglycerides (Triacylglycerol)IBA 01/2009
1	LDL Lipoproteins (beta Lipoproteins)IBA 12/2008
1	Dietary Fats (Dietary Fat)IBA 10/2008
1	Fatty Acid-Binding ProteinsIBA 10/2008
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2008
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 11/2006
1	Blood Glucose (Blood Sugar)IBA 11/2006
1	Indicators and Reagents (Reagents)IBA 02/2006
1	CytokinesIBA 10/2005
1	ProinsulinIBA 10/2004
1	Nonesterified Fatty Acids (NEFA)IBA 08/2002
1	MagnesiumIBA 05/2002
1	Calcium Gluconate (CBG)IBA 09/2001
1	Fas Ligand Protein (Fas Ligand)IBA 08/2001
1	fas Receptor (CD95 Antigen)IBA 08/2001
1	Leu Transfer RNAIBA 07/2001
1	Arginine (L-Arginine)FDA Link 07/2001
1	EnzymesIBA 01/2001
1	Metformin (Glucophage)FDA LinkGeneric 07/2000
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2000

Therapy/Procedure

3	Glycemic Control 02/2013 - 08/2002
3	Therapeutics 08/2009 - 01/2000
3	Surgical Amputation (Amputations) 01/2008 - 01/2000
2	Islets of Langerhans Transplantation 06/2008 - 07/2005
1	Organ Transplantation 06/2008
1	Kidney Transplantation 01/2008
1	Transplantation 01/2008
1	Pancreas Transplantation 07/2005
1	Electrodes (Electrode) 08/2001
1	Secondary Prevention 06/2001